Biogen (NASDAQ:BIIB) Price Target Lowered to $241.00 at HC Wainwright
Biogen (NASDAQ:BIIB – Free Report) had its price target trimmed by HC Wainwright from $300.00 to $241.00 in a report issued on Thursday,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. Other research analysts also recently issued research reports about the company. Needham & Company LLC reiterated a “hold” rating […]
Biogen (NASDAQ:BIIB – Free Report) had its price target trimmed by HC Wainwright from $300.00 to $241.00 in a report issued on Thursday,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. Other research analysts also recently issued research reports about the company. Needham & Company LLC reiterated a “hold” rating […]
